MOLLY CROSSMAN: Open Payments
NPI 1003051418 · SANFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 9 payments from 5 companies in 2025. Trend: 2023 $182 · 2024 $176 · 2025 $283
Food & beverage: $183Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $138 |
| Organon LLC | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| CooperSurgical, Inc. | 1 | $23 |
| Exeltis, USA Inc. | 1 | $17 |
Products named: NEXPLANON, MYFEMBREE, Veozah, Paragard T 380A, SLYND.
Industry payments across NC — which companies pay providers there.
